Coronary Bifurcation Lesion Clinical Trials

9 recruitingLast updated: July 25, 2026

There are 9 actively recruiting coronary bifurcation lesion clinical trials across 6 countries. Studies span Not Applicable. Top locations include Istanbul, Turkey (Türkiye), Eindhoven, North Brabant, Netherlands, Istanbul, Please Select, Turkey (Türkiye). Updated daily from ClinicalTrials.gov.


Coronary Bifurcation Lesion Trials at a Glance

9 actively recruiting trials for coronary bifurcation lesion are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Istanbul, Eindhoven, and Istanbul. Lead sponsors running coronary bifurcation lesion studies include Istanbul Mehmet Akif Ersoy Educational and Training Hospital, Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health, and Dongguan TT Medical.

Browse coronary bifurcation lesion trials by phase

About Coronary Bifurcation Lesion Clinical Trials

Looking for clinical trials for Coronary Bifurcation Lesion? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Coronary Bifurcation Lesion trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Coronary Bifurcation Lesion clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

"Expert IVUS-Eye" vs. IVUS-guided Left Main Bifurcation PCI

Coronary Artery Disease (CAD)Chronic Coronary SyndromeCoronary Bifurcation Lesion+1 more
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health50 enrolled1 locationNCT07711106
Recruiting

Crossover vs Accurate Ostial PCI for Medina 0.0.1 and 0.1.0 Left Main Bifurcation Lesions

Coronary Artery Disease (CAD)Coronary Bifurcation LesionLeft Main Coronary Artery Stenosis
Istanbul Mehmet Akif Ersoy Educational and Training Hospital1,000 enrolled2 locationsNCT07596706
Recruiting

Coronary Bifurcations With Ischaemia and Flow Assessment

Coronary Bifurcation Lesions
University of East Anglia24 enrolled1 locationNCT06971718
Recruiting

Mini-Crush Or Controlled Balloon-Crush For True Coronary Bifurcation Lesions

DeathStrokeMyocardial Infarction (MI)+2 more
Istanbul Mehmet Akif Ersoy Educational and Training Hospital400 enrolled1 locationNCT06880978
Recruiting
Not Applicable

Efficacy and Safety of Sirolimus-Coated Spiral Balloon for Coronary Bifurcation Lesions

Coronary Bifurcation Lesion
Dongguan TT Medical280 enrolled1 locationNCT06618248
Recruiting
Not Applicable

Bifurcation PCI With a Hybrid Strategy With Drug Eluting Balloons Versus a Stepwise Provisional Two-stent Strategy

Coronary Artery DiseaseCoronary Bifurcation Lesion
Cathreine BV500 enrolled1 locationNCT05731687
Recruiting

Progress Bifurcation Global Registry

Coronary Artery DiseaseCoronary Bifurcation Lesions
Minneapolis Heart Institute Foundation4,000 enrolled1 locationNCT05100992
Recruiting
Not Applicable

Sirolimus DEB in Coronary Bifurcation Lesions

Coronary Bifurcation Lesions
Shenzhen Salubris Pharmaceuticals Co., Ltd.280 enrolled1 locationNCT04896177
Recruiting

International Bifurcation Study

Coronary Bifurcation Lesion
Meshalkin Research Institute of Pathology of Circulation5,000 enrolled1 locationNCT03450577